Gryphon Financial Partners’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Gryphon Financial Partners’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,993	Closed	-$379K	–	211
2022 Q3	$379K	Hold	18,993	–	–	0.1%	120
2022 Q2	$131K	Buy	+18,993	New	+$133K	0.03%	189

Gryphon Financial Partners's FMTX Position: Q4 2022 in Review

Gryphon Financial Partners sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 18,993 shares — an estimated $379K sold.

Gryphon Financial Partners first reported a position in FMTX in Q2 2022 and held it in 2 quarters. The position peaked at $379K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Gryphon Financial Partners reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Gryphon Financial Partners sold 18,993 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $379K.
Gryphon Financial Partners first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Gryphon Financial Partners's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $379K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Gryphon Financial Partners's 13F filing for Q4 2022, filed 8 Feb 2023.